NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES. JUSR 2025, 1 (Maxsus son (FARMAKOLOGIYA, FARMATSEVTIKA), 86-86. https://doi.org/10.66301/jusr.v1i0.14971.